Trademark: 97509254
Word
LUMABRIDGE
Status Date
Tuesday, August 29, 2023
Registration Number
7152565
Registration Date
Tuesday, August 29, 2023
Filing Date
Tuesday, July 19, 2022
Published for Opposition
Tuesday, October 25, 2022
35 Providing independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Providing business intelligence services in the fields of medical devices and pharmaceuticals
45 Regulatory compliance consulting in the field of prescription drug sampling
42 Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the fields of oncology, immunology, military medicine, emergency medicine, critical care, regenerative medicine, infectious disease; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Medical research; Scientific research and development; Biomedical research services; Providing information about medical and scientific research; Research and development of vaccines and medicines; Consulting services in the fields of biotechnology and pharmaceutical research and development; Pharmaceutical research and development; Pharmaceutical drug development services; Technical research in the field of pharmaceutical studies; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines
The mark consists of the word "LumaBridge" with a pattern of radiating lines forming a semi-circle over the last 5 letters of the word portion of the mark.
Color is not claimed as a feature of the mark.
Aug 29, 2023
Notice Of Registration Confirmation Emailed
Aug 29, 2023
Registered-Principal Register
Jul 25, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 24, 2023
Allowed Principal Register - Sou Accepted
Jun 21, 2023
Statement Of Use Processing Complete
May 25, 2023
Use Amendment Filed
Jun 20, 2023
Case Assigned To Intent To Use Paralegal
May 25, 2023
Teas Statement Of Use Received
Dec 28, 2022
Automatic Update Of Assignment Of Ownership
Dec 20, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 25, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 25, 2022
Published For Opposition
Oct 5, 2022
Notification Of Notice Of Publication E-Mailed
Sep 21, 2022
Approved For Pub - Principal Register
Sep 21, 2022
Examiner's Amendment Entered
Sep 21, 2022
Notification Of Examiners Amendment E-Mailed
Sep 21, 2022
Examiners Amendment E-Mailed
Sep 21, 2022
Examiners Amendment -Written
Aug 19, 2022
Notification Of Non-Final Action E-Mailed
Aug 19, 2022
Non-Final Action E-Mailed
Aug 19, 2022
Non-Final Action Written
Aug 19, 2022
Assigned To Examiner
Aug 10, 2022
Notice Of Design Search Code E-Mailed
Aug 9, 2022
New Application Office Supplied Data Entered
Jul 22, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
